Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for RREB1
Z-value: 1.97
Motif logo
Transcription factors associated with RREB1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RREB1
|
ENSG00000124782.15 | ras responsive element binding protein 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| RREB1 | hg19_v2_chr6_+_7107830_7107993 | 0.41 | 2.0e-02 | Click! |
Activity profile of RREB1 motif
Sorted Z-values of RREB1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr12_+_54447637 | 4.55 |
ENST00000609810.1
ENST00000430889.2 |
HOXC4
HOXC4
|
homeobox C4 Homeobox protein Hox-C4 |
| chr4_-_154710210 | 3.55 |
ENST00000274063.4
|
SFRP2
|
secreted frizzled-related protein 2 |
| chr11_+_1092184 | 3.52 |
ENST00000361558.6
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming |
| chr11_+_1093318 | 3.50 |
ENST00000333592.6
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming |
| chr12_+_54384370 | 3.35 |
ENST00000504315.1
|
HOXC6
|
homeobox C6 |
| chr7_-_19157248 | 3.31 |
ENST00000242261.5
|
TWIST1
|
twist family bHLH transcription factor 1 |
| chr19_+_35609380 | 3.29 |
ENST00000604621.1
|
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr3_+_192958914 | 2.94 |
ENST00000264735.2
ENST00000602513.1 |
HRASLS
|
HRAS-like suppressor |
| chrX_-_119249819 | 2.84 |
ENST00000217999.2
|
RHOXF1
|
Rhox homeobox family, member 1 |
| chr12_-_53074182 | 2.78 |
ENST00000252244.3
|
KRT1
|
keratin 1 |
| chr12_+_54378849 | 2.71 |
ENST00000515593.1
|
HOXC10
|
homeobox C10 |
| chrX_+_151081351 | 2.57 |
ENST00000276344.2
|
MAGEA4
|
melanoma antigen family A, 4 |
| chr1_+_170632250 | 2.55 |
ENST00000367760.3
|
PRRX1
|
paired related homeobox 1 |
| chr17_+_41924511 | 2.52 |
ENST00000377203.4
ENST00000539718.1 ENST00000588884.1 ENST00000293396.8 ENST00000586233.1 |
CD300LG
|
CD300 molecule-like family member g |
| chr4_-_87374330 | 2.46 |
ENST00000511328.1
ENST00000503911.1 |
MAPK10
|
mitogen-activated protein kinase 10 |
| chr12_-_8088773 | 2.41 |
ENST00000544291.1
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3 |
| chr19_+_51358166 | 2.40 |
ENST00000601503.1
ENST00000326003.2 ENST00000597286.1 ENST00000597483.1 |
KLK3
|
kallikrein-related peptidase 3 |
| chr15_-_43513187 | 2.36 |
ENST00000540029.1
ENST00000441366.2 |
EPB42
|
erythrocyte membrane protein band 4.2 |
| chr17_-_39677971 | 2.36 |
ENST00000393976.2
|
KRT15
|
keratin 15 |
| chr16_+_28889801 | 2.27 |
ENST00000395503.4
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
| chr17_-_46703826 | 2.25 |
ENST00000550387.1
ENST00000311177.5 |
HOXB9
|
homeobox B9 |
| chr1_-_72748140 | 2.24 |
ENST00000434200.1
|
NEGR1
|
neuronal growth regulator 1 |
| chr17_+_58499844 | 2.23 |
ENST00000269127.4
|
C17orf64
|
chromosome 17 open reading frame 64 |
| chr16_+_28889703 | 2.22 |
ENST00000357084.3
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
| chr19_+_51358191 | 2.19 |
ENST00000593997.1
ENST00000595952.1 ENST00000360617.3 ENST00000598145.1 |
KLK3
|
kallikrein-related peptidase 3 |
| chr12_+_54402790 | 2.15 |
ENST00000040584.4
|
HOXC8
|
homeobox C8 |
| chr8_-_75233563 | 2.14 |
ENST00000342232.4
|
JPH1
|
junctophilin 1 |
| chr9_+_132427883 | 2.03 |
ENST00000372469.4
|
PRRX2
|
paired related homeobox 2 |
| chr4_-_87374283 | 1.97 |
ENST00000361569.2
|
MAPK10
|
mitogen-activated protein kinase 10 |
| chr9_+_96026230 | 1.93 |
ENST00000448251.1
|
WNK2
|
WNK lysine deficient protein kinase 2 |
| chr19_-_51456344 | 1.91 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
| chr19_+_36157715 | 1.82 |
ENST00000379013.2
ENST00000222275.2 |
UPK1A
|
uroplakin 1A |
| chr17_+_41924536 | 1.79 |
ENST00000317310.4
|
CD300LG
|
CD300 molecule-like family member g |
| chr19_-_51456321 | 1.77 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
| chr8_+_37553261 | 1.77 |
ENST00000331569.4
|
ZNF703
|
zinc finger protein 703 |
| chr4_-_13549417 | 1.76 |
ENST00000501050.1
|
AC006445.8
|
long intergenic non-protein coding RNA 1096 |
| chr1_-_17307173 | 1.70 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
| chr11_-_22881972 | 1.68 |
ENST00000532798.2
|
CCDC179
|
coiled-coil domain containing 179 |
| chr7_-_27153454 | 1.64 |
ENST00000522456.1
|
HOXA3
|
homeobox A3 |
| chr19_+_55999916 | 1.59 |
ENST00000587166.1
ENST00000389623.6 |
SSC5D
|
scavenger receptor cysteine rich domain containing (5 domains) |
| chr12_-_8088871 | 1.58 |
ENST00000075120.7
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3 |
| chr17_+_58227287 | 1.52 |
ENST00000300900.4
ENST00000591725.1 |
CA4
|
carbonic anhydrase IV |
| chr19_+_55999771 | 1.48 |
ENST00000594321.1
|
SSC5D
|
scavenger receptor cysteine rich domain containing (5 domains) |
| chr1_+_16083098 | 1.45 |
ENST00000496928.2
ENST00000508310.1 |
FBLIM1
|
filamin binding LIM protein 1 |
| chr6_+_43112037 | 1.45 |
ENST00000473339.1
|
PTK7
|
protein tyrosine kinase 7 |
| chr2_+_48757278 | 1.44 |
ENST00000404752.1
ENST00000406226.1 |
STON1
|
stonin 1 |
| chrX_-_48693955 | 1.43 |
ENST00000218230.5
|
PCSK1N
|
proprotein convertase subtilisin/kexin type 1 inhibitor |
| chr5_+_169758393 | 1.43 |
ENST00000521471.1
ENST00000518357.1 ENST00000436248.3 |
CTB-114C7.3
|
CTB-114C7.3 |
| chr10_+_17271266 | 1.41 |
ENST00000224237.5
|
VIM
|
vimentin |
| chr20_+_57875457 | 1.39 |
ENST00000337938.2
ENST00000311585.7 ENST00000371028.2 |
EDN3
|
endothelin 3 |
| chr12_-_6233828 | 1.39 |
ENST00000572068.1
ENST00000261405.5 |
VWF
|
von Willebrand factor |
| chr15_+_21145765 | 1.38 |
ENST00000553416.1
|
CT60
|
cancer/testis antigen 60 (non-protein coding) |
| chr2_-_74645669 | 1.37 |
ENST00000518401.1
|
C2orf81
|
chromosome 2 open reading frame 81 |
| chr11_-_89224488 | 1.35 |
ENST00000534731.1
ENST00000527626.1 |
NOX4
|
NADPH oxidase 4 |
| chr16_-_1275257 | 1.35 |
ENST00000234798.4
|
TPSG1
|
tryptase gamma 1 |
| chr12_-_16759711 | 1.33 |
ENST00000447609.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr12_+_58003935 | 1.32 |
ENST00000333972.7
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
| chrX_+_151080929 | 1.32 |
ENST00000431963.1
|
MAGEA4
|
melanoma antigen family A, 4 |
| chr20_+_4702548 | 1.32 |
ENST00000305817.2
|
PRND
|
prion protein 2 (dublet) |
| chrX_+_148863584 | 1.31 |
ENST00000439010.2
ENST00000298974.5 ENST00000522429.1 ENST00000519822.1 |
MAGEA9
|
melanoma antigen family A, 9 |
| chr2_-_128432639 | 1.29 |
ENST00000545738.2
ENST00000355119.4 ENST00000409808.2 |
LIMS2
|
LIM and senescent cell antigen-like domains 2 |
| chr12_+_49212514 | 1.29 |
ENST00000301050.2
ENST00000548279.1 ENST00000547230.1 |
CACNB3
|
calcium channel, voltage-dependent, beta 3 subunit |
| chr15_+_76629064 | 1.27 |
ENST00000290759.4
|
ISL2
|
ISL LIM homeobox 2 |
| chr16_+_21169976 | 1.27 |
ENST00000572258.1
ENST00000261388.3 ENST00000451578.2 ENST00000572599.1 ENST00000577162.1 |
TMEM159
|
transmembrane protein 159 |
| chr8_-_22550815 | 1.26 |
ENST00000317216.2
|
EGR3
|
early growth response 3 |
| chrX_+_151867214 | 1.23 |
ENST00000329342.5
ENST00000412733.1 ENST00000457643.1 |
MAGEA6
|
melanoma antigen family A, 6 |
| chrX_-_152939252 | 1.22 |
ENST00000340888.3
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chr19_+_6135646 | 1.22 |
ENST00000588304.1
ENST00000588485.1 ENST00000588722.1 ENST00000591403.1 ENST00000586696.1 ENST00000589401.1 ENST00000252669.5 |
ACSBG2
|
acyl-CoA synthetase bubblegum family member 2 |
| chr19_+_48867652 | 1.21 |
ENST00000344846.2
|
SYNGR4
|
synaptogyrin 4 |
| chr5_-_148758839 | 1.19 |
ENST00000261796.3
|
IL17B
|
interleukin 17B |
| chr19_-_51071302 | 1.19 |
ENST00000389201.3
ENST00000600381.1 |
LRRC4B
|
leucine rich repeat containing 4B |
| chr14_-_105635090 | 1.18 |
ENST00000331782.3
ENST00000347004.2 |
JAG2
|
jagged 2 |
| chr19_-_51456198 | 1.18 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
| chrX_-_148669116 | 1.18 |
ENST00000243314.5
|
MAGEA9B
|
melanoma antigen family A, 9B |
| chr19_-_47975417 | 1.18 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr2_-_85637459 | 1.17 |
ENST00000409921.1
|
CAPG
|
capping protein (actin filament), gelsolin-like |
| chr21_+_44073860 | 1.15 |
ENST00000335512.4
ENST00000539837.1 ENST00000291539.6 ENST00000380328.2 ENST00000398232.3 ENST00000398234.3 ENST00000398236.3 ENST00000328862.6 ENST00000335440.6 ENST00000398225.3 ENST00000398229.3 ENST00000398227.3 |
PDE9A
|
phosphodiesterase 9A |
| chr2_-_67442409 | 1.14 |
ENST00000414404.1
ENST00000433133.1 |
AC078941.1
|
AC078941.1 |
| chr10_+_119302508 | 1.13 |
ENST00000442245.4
|
EMX2
|
empty spiracles homeobox 2 |
| chr1_-_31712401 | 1.11 |
ENST00000373736.2
|
NKAIN1
|
Na+/K+ transporting ATPase interacting 1 |
| chr16_-_49890016 | 1.11 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
| chr21_+_44073916 | 1.10 |
ENST00000349112.3
ENST00000398224.3 |
PDE9A
|
phosphodiesterase 9A |
| chr16_+_14396121 | 1.09 |
ENST00000570945.1
|
RP11-65J21.3
|
RP11-65J21.3 |
| chr3_-_137834436 | 1.09 |
ENST00000327532.2
ENST00000467030.1 |
DZIP1L
|
DAZ interacting zinc finger protein 1-like |
| chr9_+_35906176 | 1.09 |
ENST00000354323.2
|
HRCT1
|
histidine rich carboxyl terminus 1 |
| chr2_+_28618532 | 1.08 |
ENST00000545753.1
|
FOSL2
|
FOS-like antigen 2 |
| chr12_-_16760021 | 1.07 |
ENST00000540445.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr11_+_7506837 | 1.07 |
ENST00000528758.1
|
OLFML1
|
olfactomedin-like 1 |
| chrX_+_153813407 | 1.06 |
ENST00000443287.2
ENST00000333128.3 |
CTAG1A
|
cancer/testis antigen 1A |
| chr8_+_58106143 | 1.05 |
ENST00000521653.1
ENST00000518556.1 |
RP11-513O17.2
|
RP11-513O17.2 |
| chrX_+_102585124 | 1.04 |
ENST00000332431.4
ENST00000372666.1 |
TCEAL7
|
transcription elongation factor A (SII)-like 7 |
| chr3_+_8775466 | 1.04 |
ENST00000343849.2
ENST00000397368.2 |
CAV3
|
caveolin 3 |
| chr19_-_47975106 | 1.03 |
ENST00000539381.1
ENST00000594353.1 ENST00000542837.1 |
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr1_+_164528866 | 1.03 |
ENST00000420696.2
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
| chr10_+_127661942 | 1.02 |
ENST00000417114.1
ENST00000445510.1 ENST00000368691.1 |
FANK1
|
fibronectin type III and ankyrin repeat domains 1 |
| chr17_+_58499066 | 1.02 |
ENST00000474834.1
|
C17orf64
|
chromosome 17 open reading frame 64 |
| chr12_+_26348429 | 1.02 |
ENST00000242729.2
|
SSPN
|
sarcospan |
| chr13_-_72441315 | 1.02 |
ENST00000305425.4
ENST00000313174.7 ENST00000354591.4 |
DACH1
|
dachshund homolog 1 (Drosophila) |
| chr7_-_102257139 | 1.01 |
ENST00000521076.1
ENST00000462172.1 ENST00000522801.1 ENST00000449970.2 ENST00000262940.7 |
RASA4
|
RAS p21 protein activator 4 |
| chr22_-_44258360 | 1.01 |
ENST00000330884.4
ENST00000249130.5 |
SULT4A1
|
sulfotransferase family 4A, member 1 |
| chr11_+_46402744 | 1.01 |
ENST00000533952.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr12_+_26348246 | 1.01 |
ENST00000422622.2
|
SSPN
|
sarcospan |
| chr12_-_16760195 | 1.00 |
ENST00000546281.1
ENST00000537757.1 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr17_+_1958388 | 1.00 |
ENST00000399849.3
|
HIC1
|
hypermethylated in cancer 1 |
| chr8_+_58106173 | 1.00 |
ENST00000523341.1
|
RP11-513O17.2
|
RP11-513O17.2 |
| chrX_+_148864169 | 1.00 |
ENST00000523516.1
|
MAGEA9
|
melanoma antigen family A, 9 |
| chr1_-_6240183 | 0.99 |
ENST00000262450.3
ENST00000378021.1 |
CHD5
|
chromodomain helicase DNA binding protein 5 |
| chr4_+_123747834 | 0.99 |
ENST00000264498.3
|
FGF2
|
fibroblast growth factor 2 (basic) |
| chr6_+_151646800 | 0.99 |
ENST00000354675.6
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr10_+_115438920 | 0.98 |
ENST00000429617.1
ENST00000369331.4 |
CASP7
|
caspase 7, apoptosis-related cysteine peptidase |
| chr20_+_34700333 | 0.97 |
ENST00000441639.1
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chrX_-_151922340 | 0.96 |
ENST00000370284.1
ENST00000543232.1 ENST00000393876.1 ENST00000393872.3 |
MAGEA2
|
melanoma antigen family A, 2 |
| chr18_-_21242833 | 0.96 |
ENST00000586087.1
ENST00000592179.1 |
ANKRD29
|
ankyrin repeat domain 29 |
| chrX_-_151938171 | 0.92 |
ENST00000393902.3
ENST00000417212.1 ENST00000370278.3 |
MAGEA3
|
melanoma antigen family A, 3 |
| chr11_+_1897697 | 0.92 |
ENST00000432093.1
|
LSP1
|
lymphocyte-specific protein 1 |
| chr7_+_75932863 | 0.92 |
ENST00000429938.1
|
HSPB1
|
heat shock 27kDa protein 1 |
| chr19_-_18995029 | 0.91 |
ENST00000596048.1
|
CERS1
|
ceramide synthase 1 |
| chrX_-_153847522 | 0.91 |
ENST00000328435.2
ENST00000359887.4 |
CTAG1B
|
cancer/testis antigen 1B |
| chr1_+_157963063 | 0.91 |
ENST00000360089.4
ENST00000368173.3 ENST00000392272.2 |
KIRREL
|
kin of IRRE like (Drosophila) |
| chr15_-_23692381 | 0.90 |
ENST00000567107.1
ENST00000345070.5 ENST00000312015.5 |
GOLGA6L2
|
golgin A6 family-like 2 |
| chr19_-_9006766 | 0.89 |
ENST00000599436.1
|
MUC16
|
mucin 16, cell surface associated |
| chrX_-_70150939 | 0.89 |
ENST00000374299.3
ENST00000298085.4 |
SLC7A3
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 |
| chr11_-_35547277 | 0.88 |
ENST00000527605.1
|
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
| chr11_+_125034586 | 0.88 |
ENST00000298282.9
|
PKNOX2
|
PBX/knotted 1 homeobox 2 |
| chr11_-_35547151 | 0.87 |
ENST00000378878.3
ENST00000529303.1 ENST00000278360.3 |
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
| chr12_-_56101647 | 0.87 |
ENST00000347027.6
ENST00000257879.6 ENST00000257880.7 ENST00000394230.2 ENST00000394229.2 |
ITGA7
|
integrin, alpha 7 |
| chr17_-_58499698 | 0.86 |
ENST00000590297.1
|
USP32
|
ubiquitin specific peptidase 32 |
| chr17_-_62658186 | 0.85 |
ENST00000262435.9
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2 |
| chr11_+_7506584 | 0.85 |
ENST00000530135.1
|
OLFML1
|
olfactomedin-like 1 |
| chr1_-_153538292 | 0.84 |
ENST00000497140.1
ENST00000368708.3 |
S100A2
|
S100 calcium binding protein A2 |
| chr13_+_111972980 | 0.84 |
ENST00000283547.1
|
TEX29
|
testis expressed 29 |
| chr4_-_77996032 | 0.83 |
ENST00000505609.1
|
CCNI
|
cyclin I |
| chr11_+_46403194 | 0.83 |
ENST00000395569.4
ENST00000395566.4 |
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr15_+_75498739 | 0.82 |
ENST00000565074.1
|
C15orf39
|
chromosome 15 open reading frame 39 |
| chr2_+_177001685 | 0.82 |
ENST00000432796.2
|
HOXD3
|
homeobox D3 |
| chr11_+_46403303 | 0.81 |
ENST00000407067.1
ENST00000395565.1 |
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr8_+_38261880 | 0.81 |
ENST00000527175.1
|
LETM2
|
leucine zipper-EF-hand containing transmembrane protein 2 |
| chr11_-_64703354 | 0.80 |
ENST00000532246.1
ENST00000279168.2 |
GPHA2
|
glycoprotein hormone alpha 2 |
| chr17_+_38296576 | 0.80 |
ENST00000264645.7
|
CASC3
|
cancer susceptibility candidate 3 |
| chr2_+_28974531 | 0.79 |
ENST00000420282.1
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme |
| chr8_+_95653840 | 0.79 |
ENST00000520385.1
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr20_+_23168759 | 0.77 |
ENST00000411595.1
|
RP4-737E23.2
|
RP4-737E23.2 |
| chrX_-_8769378 | 0.75 |
ENST00000543214.1
ENST00000381003.3 |
FAM9A
|
family with sequence similarity 9, member A |
| chr17_-_41132088 | 0.75 |
ENST00000591916.1
ENST00000451885.2 ENST00000454303.1 |
PTGES3L
PTGES3L-AARSD1
|
prostaglandin E synthase 3 (cytosolic)-like PTGES3L-AARSD1 readthrough |
| chr12_-_48214345 | 0.74 |
ENST00000433685.1
ENST00000447463.1 ENST00000427332.2 |
HDAC7
|
histone deacetylase 7 |
| chr19_-_44306590 | 0.74 |
ENST00000377950.3
|
LYPD5
|
LY6/PLAUR domain containing 5 |
| chr1_-_228604328 | 0.73 |
ENST00000355586.4
ENST00000366698.2 ENST00000520264.1 ENST00000479800.1 ENST00000295033.3 |
TRIM17
|
tripartite motif containing 17 |
| chr4_+_123747979 | 0.73 |
ENST00000608478.1
|
FGF2
|
fibroblast growth factor 2 (basic) |
| chr10_-_61122625 | 0.72 |
ENST00000468840.2
|
FAM13C
|
family with sequence similarity 13, member C |
| chr7_+_76101379 | 0.72 |
ENST00000429179.1
|
DTX2
|
deltex homolog 2 (Drosophila) |
| chr12_+_26348582 | 0.72 |
ENST00000535504.1
|
SSPN
|
sarcospan |
| chr18_+_77160282 | 0.71 |
ENST00000318065.5
ENST00000545796.1 ENST00000592223.1 ENST00000329101.4 ENST00000586434.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
| chr18_-_3874271 | 0.71 |
ENST00000400149.3
ENST00000400155.1 ENST00000400150.3 |
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1 |
| chr7_-_132262060 | 0.69 |
ENST00000359827.3
|
PLXNA4
|
plexin A4 |
| chr11_-_71791726 | 0.69 |
ENST00000393695.3
|
NUMA1
|
nuclear mitotic apparatus protein 1 |
| chrX_-_151903184 | 0.69 |
ENST00000357916.4
ENST00000393869.3 |
MAGEA12
|
melanoma antigen family A, 12 |
| chr8_-_145578505 | 0.68 |
ENST00000526263.1
ENST00000398633.3 |
TMEM249
|
transmembrane protein 249 |
| chr4_+_164265035 | 0.67 |
ENST00000338566.3
|
NPY5R
|
neuropeptide Y receptor Y5 |
| chr19_-_3025614 | 0.67 |
ENST00000447365.2
|
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
| chr9_+_93921855 | 0.67 |
ENST00000423719.2
ENST00000609752.1 |
LINC00484
|
long intergenic non-protein coding RNA 484 |
| chr11_-_71791435 | 0.67 |
ENST00000351960.6
ENST00000541719.1 ENST00000535111.1 |
NUMA1
|
nuclear mitotic apparatus protein 1 |
| chr11_+_7506713 | 0.67 |
ENST00000329293.3
ENST00000534244.1 |
OLFML1
|
olfactomedin-like 1 |
| chr10_+_52751010 | 0.67 |
ENST00000373985.1
|
PRKG1
|
protein kinase, cGMP-dependent, type I |
| chrX_-_151306982 | 0.67 |
ENST00000444834.2
ENST00000579960.1 |
MAGEA10
|
melanoma antigen family A, 10 |
| chrX_+_151883090 | 0.67 |
ENST00000370293.2
ENST00000423993.1 ENST00000447530.1 ENST00000458057.1 ENST00000331220.2 ENST00000422085.1 ENST00000453150.1 ENST00000409560.1 |
MAGEA2B
|
melanoma antigen family A, 2B |
| chr8_+_72755367 | 0.67 |
ENST00000537896.1
|
RP11-383H13.1
|
Protein LOC100132891; cDNA FLJ53548 |
| chr2_+_105471969 | 0.66 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
| chrX_-_153881842 | 0.66 |
ENST00000369585.3
ENST00000247306.4 |
CTAG2
|
cancer/testis antigen 2 |
| chr17_+_54671047 | 0.65 |
ENST00000332822.4
|
NOG
|
noggin |
| chr11_-_71791518 | 0.65 |
ENST00000537217.1
ENST00000366394.3 ENST00000358965.6 ENST00000546131.1 ENST00000543937.1 ENST00000368959.5 ENST00000541641.1 |
NUMA1
|
nuclear mitotic apparatus protein 1 |
| chr2_+_106468204 | 0.64 |
ENST00000425756.1
ENST00000393349.2 |
NCK2
|
NCK adaptor protein 2 |
| chr8_-_22550691 | 0.64 |
ENST00000519492.1
|
EGR3
|
early growth response 3 |
| chr3_+_140660634 | 0.63 |
ENST00000446041.2
ENST00000507429.1 ENST00000324194.6 |
SLC25A36
|
solute carrier family 25 (pyrimidine nucleotide carrier ), member 36 |
| chr20_+_55967129 | 0.61 |
ENST00000371219.2
|
RBM38
|
RNA binding motif protein 38 |
| chr6_-_35480705 | 0.61 |
ENST00000229771.6
|
TULP1
|
tubby like protein 1 |
| chr18_-_21242774 | 0.61 |
ENST00000322980.9
|
ANKRD29
|
ankyrin repeat domain 29 |
| chr20_+_62697564 | 0.60 |
ENST00000458442.1
|
TCEA2
|
transcription elongation factor A (SII), 2 |
| chr11_+_125034640 | 0.59 |
ENST00000542175.1
|
PKNOX2
|
PBX/knotted 1 homeobox 2 |
| chr12_-_95044309 | 0.59 |
ENST00000261226.4
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
| chr18_+_33877654 | 0.59 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr12_-_57644952 | 0.59 |
ENST00000554578.1
ENST00000546246.2 ENST00000553489.1 ENST00000332782.2 |
STAC3
|
SH3 and cysteine rich domain 3 |
| chr10_-_61122934 | 0.58 |
ENST00000512919.1
|
FAM13C
|
family with sequence similarity 13, member C |
| chr11_-_118789613 | 0.58 |
ENST00000532899.1
|
BCL9L
|
B-cell CLL/lymphoma 9-like |
| chr3_-_38991853 | 0.58 |
ENST00000456224.3
|
SCN11A
|
sodium channel, voltage-gated, type XI, alpha subunit |
| chr19_+_14544099 | 0.57 |
ENST00000242783.6
ENST00000586557.1 ENST00000590097.1 |
PKN1
|
protein kinase N1 |
| chr6_-_35480640 | 0.55 |
ENST00000428978.1
ENST00000322263.4 |
TULP1
|
tubby like protein 1 |
| chr19_-_44084586 | 0.54 |
ENST00000599693.1
ENST00000598165.1 |
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1 |
| chr11_+_818902 | 0.54 |
ENST00000336615.4
|
PNPLA2
|
patatin-like phospholipase domain containing 2 |
| chr7_+_95401851 | 0.54 |
ENST00000447467.2
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1 |
| chr5_-_37835010 | 0.54 |
ENST00000510177.1
|
GDNF
|
glial cell derived neurotrophic factor |
| chr15_-_35088340 | 0.54 |
ENST00000290378.4
|
ACTC1
|
actin, alpha, cardiac muscle 1 |
| chr3_+_57094469 | 0.53 |
ENST00000334325.1
|
SPATA12
|
spermatogenesis associated 12 |
| chr1_+_110091189 | 0.53 |
ENST00000369851.4
|
GNAI3
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
| chr14_-_69444957 | 0.53 |
ENST00000556571.1
ENST00000553659.1 ENST00000555616.1 |
ACTN1
|
actinin, alpha 1 |
| chr10_+_102758105 | 0.53 |
ENST00000429732.1
|
LZTS2
|
leucine zipper, putative tumor suppressor 2 |
| chr18_+_9334755 | 0.52 |
ENST00000262120.5
|
TWSG1
|
twisted gastrulation BMP signaling modulator 1 |
| chr17_+_78193443 | 0.51 |
ENST00000577155.1
|
SLC26A11
|
solute carrier family 26 (anion exchanger), member 11 |
| chrX_-_151903101 | 0.51 |
ENST00000393900.3
|
MAGEA12
|
melanoma antigen family A, 12 |
| chr3_+_53195517 | 0.51 |
ENST00000487897.1
|
PRKCD
|
protein kinase C, delta |
| chr12_-_62653903 | 0.51 |
ENST00000552075.1
|
FAM19A2
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of RREB1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 4.5 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
| 1.2 | 3.6 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 1.1 | 3.3 | GO:2000276 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.9 | 9.5 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.8 | 4.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.6 | 1.7 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 0.5 | 3.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
| 0.4 | 2.7 | GO:0030421 | defecation(GO:0030421) |
| 0.4 | 4.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.3 | 1.0 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.3 | 1.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.3 | 4.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.3 | 0.9 | GO:0072720 | cellular response to mycotoxin(GO:0036146) response to dithiothreitol(GO:0072720) |
| 0.3 | 3.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.2 | 3.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 | 1.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.2 | 0.9 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.2 | 0.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 | 2.5 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.2 | 2.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 | 3.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 0.2 | 2.0 | GO:0032888 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.2 | 0.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.2 | 1.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.2 | 0.5 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
| 0.2 | 2.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 1.0 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 2.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 4.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 1.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 0.5 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
| 0.1 | 0.7 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.1 | 0.7 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.1 | 2.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 0.9 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
| 0.1 | 0.5 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.1 | 0.9 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.1 | 1.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 | 1.0 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.1 | 1.0 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 1.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 0.6 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.1 | 1.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 | 0.5 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.1 | 1.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.1 | 2.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
| 0.1 | 0.7 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 | 0.6 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.1 | 1.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 | 0.5 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 | 0.5 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.1 | 1.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.1 | 1.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.1 | 0.8 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.1 | 1.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.9 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.1 | 0.9 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 0.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 0.3 | GO:0061150 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.1 | 0.3 | GO:1901994 | meiotic DNA integrity checkpoint(GO:0044778) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.1 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 0.3 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 1.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 | 0.9 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 | 1.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.1 | 1.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.1 | 0.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 | 0.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.1 | 0.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 | 0.4 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.1 | 0.5 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 | 2.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 1.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.1 | 1.1 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 0.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 | 1.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.9 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 5.2 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.0 | 0.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.0 | 1.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 1.1 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 0.2 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
| 0.0 | 0.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.0 | 0.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.0 | 0.3 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 | 1.4 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.0 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.0 | 11.7 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
| 0.0 | 1.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 0.0 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.0 | 0.1 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.0 | 0.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 | 0.4 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.0 | 0.7 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.0 | 1.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 | 0.5 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.0 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.0 | 0.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.0 | 0.7 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.0 | 0.2 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 | 0.3 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.0 | 0.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 | 1.1 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 | 1.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.0 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.0 | 0.4 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 | 3.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.0 | 0.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.0 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.0 | 1.2 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 0.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.0 | 0.9 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.0 | 0.6 | GO:0050718 | positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.0 | 0.8 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 | 1.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.1 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) |
| 0.0 | 0.8 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 | 1.0 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.6 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 1.3 | GO:0060271 | cilium morphogenesis(GO:0060271) |
| 0.0 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.0 | 0.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.0 | 1.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.4 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.0 | 0.6 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.0 | 1.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 2.5 | GO:0030518 | intracellular steroid hormone receptor signaling pathway(GO:0030518) |
| 0.0 | 0.9 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.0 | 0.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 | 0.6 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.0 | 0.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.0 | 0.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 | 0.3 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.0 | 1.0 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 7.0 | GO:0070702 | inner mucus layer(GO:0070702) outer mucus layer(GO:0070703) |
| 0.7 | 4.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.3 | 0.8 | GO:0044299 | C-fiber(GO:0044299) |
| 0.2 | 2.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.2 | 2.0 | GO:0055028 | cortical microtubule(GO:0055028) |
| 0.2 | 2.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.2 | 4.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 4.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.1 | 0.5 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.1 | 2.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.1 | 0.5 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.1 | 0.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.1 | 0.4 | GO:0031251 | PAN complex(GO:0031251) |
| 0.1 | 2.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 0.9 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 1.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 0.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.1 | 1.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 1.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.1 | 1.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.1 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 0.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.1 | 0.6 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.1 | 0.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.1 | 0.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 1.2 | GO:0000800 | lateral element(GO:0000800) |
| 0.0 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.0 | 1.7 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.0 | 0.5 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.0 | 0.1 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 1.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 1.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.0 | 3.0 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 2.3 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 0.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 0.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 1.8 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 3.2 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
| 0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 4.5 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 4.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 1.5 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 2.7 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 1.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 1.1 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 0.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.0 | 1.4 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 2.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 1.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 4.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.4 | 3.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.4 | 4.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.3 | 1.0 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.3 | 1.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.3 | 9.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 0.8 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.2 | 1.0 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.2 | 1.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 0.9 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.2 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 0.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.2 | 0.6 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.2 | 1.4 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.2 | 2.8 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.2 | 0.7 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.2 | 2.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.2 | 1.4 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.2 | 0.8 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.1 | 5.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.1 | 2.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 4.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 0.9 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.1 | 0.6 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 0.6 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.1 | 2.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 1.0 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 1.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 2.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 0.7 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.1 | 3.8 | GO:0043236 | laminin binding(GO:0043236) |
| 0.1 | 0.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.1 | 1.5 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.1 | 0.7 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.1 | 0.6 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 0.5 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 0.9 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 1.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.1 | 3.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 0.2 | GO:0004641 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
| 0.1 | 0.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 0.2 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.1 | 1.2 | GO:0047617 | very long-chain fatty acid-CoA ligase activity(GO:0031957) acyl-CoA hydrolase activity(GO:0047617) |
| 0.0 | 1.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 1.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.0 | 0.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.0 | 1.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 1.4 | GO:0031005 | filamin binding(GO:0031005) |
| 0.0 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.0 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) ER retention sequence binding(GO:0046923) |
| 0.0 | 0.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.0 | 3.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.0 | 1.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.0 | 0.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.0 | 0.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.0 | 0.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.0 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.0 | 0.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.0 | 1.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.0 | 4.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.0 | 0.8 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 1.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.0 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 1.0 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.0 | 2.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.0 | 0.4 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.0 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.0 | 0.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.0 | 0.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.0 | 0.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
| 0.0 | 0.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.0 | 1.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.0 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 0.1 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.0 | 1.0 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 2.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.0 | 1.0 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 0.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.0 | 0.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.0 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.0 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 0.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.0 | 1.3 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.0 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.0 | 1.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 0.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.0 | 1.1 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.9 | GO:0046332 | SMAD binding(GO:0046332) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 6.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 8.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 5.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 4.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 1.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.0 | 1.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 4.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 1.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.0 | 1.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.0 | 1.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 1.6 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 1.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 1.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 2.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.0 | 1.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 2.0 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 1.6 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 1.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 1.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 1.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 3.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 1.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.6 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.0 | 0.8 | PID PLK1 PATHWAY | PLK1 signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.2 | 7.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.2 | 7.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.2 | 4.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 4.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 4.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 1.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 1.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.1 | 2.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 3.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 1.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.1 | 2.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 2.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 2.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 1.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 1.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 0.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.0 | 0.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.0 | 1.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.0 | 0.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.0 | 2.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 0.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 0.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.0 | 0.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.0 | 0.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 1.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 1.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |